<DOC>
	<DOCNO>NCT00205400</DOCNO>
	<brief_summary>Hypothesis : Does time spend within target INR range differ patient manage AMD IT model anticoagulation care ? Experimental Design : The 36-month trial enrol 192 eligible patient currently receive chronic warfarin therapy William S. Middleton Memorial VA Hospital . Consenting patient enrol randomized 1 2 group : usual clinic care face-to-face visit every 4 week ( AMS model ) clinic visit every 3 month interim laboratory visit telephone follow-up every 4 week ( IT model ) . At study conclusion , amount time INR within target range compare two group . Thromboembolic bleed event rate , patient knowledge , quality life healthcare utilization also analyze .</brief_summary>
	<brief_title>Comparison Patient Outcomes Using Different Delivery Models Anticoagulation Care</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>completion &gt; 3 month warfarin indefinite warfarin therapy patient currently receive &gt; 25 % INR determination per year local lab extend absence VA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>